SCHEMBL4613432

SCHEMBL4613432

COc1cc(O)cc(OC)c1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.61
MAPT P10636 1/20 0.61
PTGS2 P35354 6/20 0.52
ALOX5 P09917 5/20 0.52
MAOB P27338 1/20 0.50
CHRM1 P11229 1/20 0.46
ALOX15 P16050 1/20 0.46
MAOA P21397 1/20 0.46
TBXA2R P21731 1/20 0.46
ADRA1A P35348 1/20 0.46
HTR2B P41595 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP1A1 P04798 1/20 0.41
PTGS1 P23219 1/20 0.41
ERN1 O75460 1/20 0.39
TTR P02766 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10663410 0.88 CYP3A4 (0.56) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL7289424 0.86 CYP3A4 (0.62) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL3155200 0.84 CYP3A4 (0.50) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL16659617 0.84 CYP3A4 (0.50) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL69105 0.78 ALOX5 (0.57) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL8064768 0.78 CYP3A4 (0.67) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL70379 0.78 ALOX5 (0.70) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL10885926 0.77 CYP3A4 (0.53) CYP3A4MAPTALOX5MAOBERN1
SCHEMBL2388019 0.77 CYP3A4 (0.71) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL10196078 0.76 ACHE (0.59) CYP3A4MAPTTDP1HPGDERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481730-B1 Process for the production of phenolic compounds using zeolite beta of the proton-type, UBE INDUSTRIES (JP) 2008-01-23 EP disclosed
US-7285688-B2 Proton type β zeolite, preparation method thereof and process for preparing phenol compound using the same UBE INDUSTRIES, LTD. (JP) 2007-10-23 US disclosed
US-20040242938-A1 Novel proton type beta zeolite, preparation method thereof and process for preparing phenol compound using the same UBE INDUSTRIES, LTD. (JP) 2004-12-02 US disclosed
EP-1481730-A1 New zeolite beta of the proton-type, process for its preparation and production of phenolic compounds using the same Ube Industries, Ltd. (JP) 2004-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242938-A1 Novel proton type beta zeolite, preparation method thereof and process for preparing phenol compound using the same HPD, PAH, TPSD1 CYP3A4 1280/4885MAPT 3796/4885PTGS2 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.